PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Verizon

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Transformative Technology to Deliver an Innovative Tuberculosis Treatment - Tuberculosis (TB) is the second leading cause of infectious-disease deaths and has killed more people globally than all other pandemics combined. In the U.S., California, New York, Texas and Florida now account for more than half of TB cases nationally
Transformative Technology to Deliver an Innovative Tuberculosis Treatment

 

NewswireToday - /newswire/ - San Diego, CA, United States, 2013/08/15 - Tuberculosis (TB) is the second leading cause of infectious-disease deaths and has killed more people globally than all other pandemics combined. In the U.S., California, New York, Texas and Florida now account for more than half of TB cases nationally. NYSE, NASDAQ: VZ

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The disease is curable if treated properly. Patients are typically required to follow a strict antibiotic regimen, which generally entails taking a combination of daily pills for six months. In some cases, government health departments are involved and require healthcare workers to visit patients daily and observe them taking their medication. The procedure is costly and intrusive to patients, which is why some of them stop following their treatment plan.

To address this problem, the Verizon Foundation teamed with University of California at San Diego (UC San Diego), to demonstrate a new therapy system that uses mobile and cloud technology to help ensure TB patients follow their critical treatment.

By providing funding, smartphones and leveraging Verizon’s healthcare enabled cloud solution, Verizon Foundation is enabling researchers at UC San Diego, Qualcomm Institute and Calit2, to deliver an innovative mHealth treatment program called Video Directly Observed Therapy (VDOT).

VDOT enables TB patients to record their daily treatments on video-enabled smartphones, upload and store their videos securely on Verizon’s healthcare enabled cloud, and send the videos to their health department, where health officials can remotely monitor treatment compliance e. This solution avoids the stigma TB treatments can have on patients and can curtail poor medication adherence, which has led to the emergence of drug-resistant strains of the bacterium.

“Our collaboration with UC San Diego demonstrates the power of public and private partnerships to scale innovation to improve health outcomes for those who need it most,” said Anthony Llompart, director healthcare, Verizon Foundation. “The VDOT program leverages technology to enable improved access and quality of healthcare, making UC San Diego an ideal partner for Verizon’s Innovative Healthcare Initiative.”

The UC San Diego and the Verizon Foundation will demonstrate the VDOT therapy solution on Thursday, August, 15, 2013 at the university's main campus. The demo will also stream live at 2 pm. ET.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Verizon

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Transformative Technology to Deliver an Innovative Tuberculosis Treatment

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Tuberculosis Treatment | Verizon
Publisher Contact: Carlos Arcila - Verizon.com 
905-559-8031 carlos.arcila[.]verizon.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Verizon securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Verizon / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Frost & Sullivan Honors Linguamatics for Developing a Best-in-Class NLP-based Data Mining Platform for the Healthcare Industry
Therapist Launches Podcast to Reach Larger Audience
Top Innovative Health and Wellness Technologies to Accelerate Global Adoption of Precision Medicine Finds Frost & Sullivan
Rheumatoid Arthritis Diagnosis Tests Market Size to Expand At 6.2% CAGR through 2022 Says PMR
Persistence Market Research Publishes Health Information Exchange Market Opportunities and Forecasts 2017-2025
Persistence Market Research Publishes Microtome Cryostat Equipment Market Opportunities and Forecasts, 2017-2025
North America to Account for 4.3% CAGR in Global Hip Replacement Market Reports Persistence Market Research
HPMC Capsules Market to Register 10.9% CAGR During 2017-2025 Finds Persistence Market Research
Persistence Market Research Publishes Blood Thinner Market Opportunities and Forecasts 2017-2025
Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)